Doherty, Daniel J. http://orcid.org/0000-0002-6492-5817
Sykes, Robert http://orcid.org/0000-0003-1010-5474
Mangion, Kenneth http://orcid.org/0000-0002-3505-7440
Berry, Colin http://orcid.org/0000-0002-4547-8636
Article History
Accepted: 8 January 2021
First Online: 23 February 2021
Declarations
:
: This article does not contain any studies with human or animal subjects performed by any of the authors.
: CB is employed by the University of Glasgow which holds consultancy and research agreements for his work with companies that have commercial interests in cardiovascular disease. The companies include Abbott Vascular, AstraZeneca, Boehringer Ingelheim, GSK, HeartFlow, Medyria, Menarini, Neovasc, Novartis, and Siemens Healthcare. None of the other authors have any potential conflicts of interest.